Article
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Diabetes Increases Cardiovascular Risk in Patients With Psoriasis, Coronary Artery Disease
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
Risankizumab Found Effective in Patients With Moderate Plaque Psoriasis
Defining On-Treatment Remission in Plaque Psoriasis
Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests
Low BSA in Psoriasis May Still Mean High Disease Burden